Back to results
US 7,019,023 B2Granted
Benzothiepine 1, 1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
AssigneeAventis Pharma Deutschland GmbH
InventorsWendelin Frick, Alfons Enhsen, Heiner Glombik, Hubert Heuer
Life of this patent
Estimating the term…
Abstract
Substituted benzothiepine 1,1-dioxide derivatives of formula I: in which R1, R2, R3, R4, R5 and Z have the meanings indicated, and their physiologically tolerable salts and physiologically functional derivatives and a process for their preparation are described. The compounds are suitable, for example, as hypolipidemics.
Claims10
A coated pharmaceutical composition comprising at least one compound of formula I
- in which
- R1 is methyl, ethyl, propyl, or butyl;
- R2 is H, OH, NH2, or NH—(C1–C6)-alkyl;
- R3 is a sugar radical, a disugar radical, a trisugar radical, or a tetrasugar radical, wherein said radicals are optionally mono- or polysubstituted by a sugar protective group;
- R4 is methyl, ethyl, propyl, or butyl;
- R5 is methyl, ethyl, propyl, or butyl;
- Z is —(C═O)n—(C0–C16)-alkyl, —(C═O)n—(C0–C16)-alkyl-NH—, —(C═O)n—(C0–C16)-alkyl-O—, —(C═O)n—(C1–C16)-alkyl-(C═O)m, or a covalent bond;
- n is 0 or 1;
- m is 0 or 1;
- or a pharmaceutically tolerable salt thereof, or a physiologically functional derivative thereof,
- and at least one pharmacologically tolerable excipient.
8 more elements
Dependencies are inferred from the claim text.